Two consumer-focused companies and a wider industry shift illustrate a change in wearable design: devices that only measure physiology are being joined by wearables that both measure and intervene. Vibe Science is running a beta of its Domayn Mask, which the company says delivers timed light and sound pulses to nudge users toward calmer or more focused states. Elemind has sold a commercial EEG headband since 2024 that reads brain activity and applies precisely timed acoustic stimulation to speed sleep onset, the company and Healthcare Outlook say.
Read-only wearables collect signals but do not directly change physiology. Examples include heart-rate watches, sleep rings and continuous glucose monitors that report metrics back to users or clinicians. Read-write devices add an output: insulin pumps that inject insulin when glucose rises, stimulators that apply electrical pulses to a nerve, or headsets that time sound or light to brain activity.
Vibe Science describes the Domayn Mask as a sensory stimulus intended to drive steady-state visual evoked potential (SSVEP) entrainment in the cortex. The company says it monitors autonomic shifts with heart-rate-variability markers such as RMSSD and SDNN and reports reductions in LF/HF ratio, which it links to lower arousal and faster sleep or improved focus in different modes. Those claims come from the company’s internal studies and product materials.
Elemind says its headband uses high-fidelity EEG to model a user’s neural state moment by moment and deliver phase-timed acoustic pulses. The company frames the system as a closed-loop intervention grounded in peer-reviewed clinical research and protected by patents. “We are laying the foundation for how humans will interact with their own brains safely, non-invasively, and intelligently,” CEO Meredith Perry said in a company statement.
Industry obstacles remain. The sector still faces accuracy and adherence limits, fragmented electronic health record integration, regulatory complexity, cybersecurity risks and equity barriers, according to market materials cited by Arterex and other sources. For now, many read-write claims rest on company studies or early trials rather than large-scale independent replication.
As these devices move beyond labs, buyers and clinicians will need clearer evidence, defined safety boundaries and standards for how sensing and stimulation are combined in consumer products.
Photo credit: www.miamiherald.com
Tags: wearable neurotech, EEG, sleep technology, neuromodulation
Topics: Wearable neurotech, EEG & neuro-sensing headsets, Sleep technology